P1042: COMPARISON OF THE RESPONSE TO ROPEGINTERFERON ALFA-2B IN HYDROXYUREA NAÏVE VERSUS RESISTANCE/INTOLERANCE POLYCYTHEMIA VERA: THE KOREAN SINGLE-ARM, OPEN-LABEL MULTICENTER STUDY

Bibliographic Details
Published in:	HemaSphere
Main Authors:	Sung-Eun Lee, Sung-Soo Yoon, Deok-Hwan Yang, Gyeong-Won Lee, Seug Yun Yoon, Sang Kyun Sohn, Ho-Jin Shin, Sung Hwa Bae, Chul Won Choi, Eun-Ji Choi, June-Won Cheong, Soo-Mee Bang, Joon Seong Park, Suk Joong Oh, Young Park, Young Hoon Park
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000971064.86929.d8

Similar Items

A Case Report of Ropeginterferon Alfa-2b for Polycythemia Vera during Pregnancy
by: Su-Yeon Bang, et al.
Published: (2023-03-01)

Cost–effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera
by: Aaron T Gerds, et al.
Published: (2023-08-01)

Change in Polycythemia Vera Treatment: Ropeginterferon Alfa-2b in Light of Current Trials
by: Heinz Gisslinger
Published: (2023-12-01)

Event‐free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa‐2b or hydroxyurea/best available therapy (PROUD‐PV/CONTINUATION‐PV)
by: Jean‐Jacques Kiladjian, et al.
Published: (2025-05-01)

Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b
by: Albert Qin, et al.
Published: (2024-09-01)

Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera
by: Albert Qin, et al.
Published: (2025-06-01)

PB2207: NEUTROPHIL–TO-LYMPHOCYTE RATIO IS AN EARLY SCREENING TOOL FOR DIAGNOSIS OF POLYCYTHEMIA VERA
by: Seug Yun Yoon, et al.
Published: (2023-08-01)

Prevalence and clinical outcomes of polycythemia vera and essential thrombocythemia with hydroxyurea resistance or intolerance
by: Kittitat Chiaranairungrot, et al.
Published: (2022-12-01)

Evaluation of the Benefit of Ropeginterferon Treatment in Patients with Polycythemia Vera
by: Diana GRASU, et al.
Published: (2025-03-01)

Prognostic value of modified criteria for hydroxyurea resistance or intolerance in patients with high‐risk essential thrombocythemia
by: Young Hoon Park, et al.
Published: (2023-04-01)

C020 | REAL-WORLD OUTCOMES OF ROPEGINTERFERON ALFA-2B IN POLYCYTHEMIA VERA: IMPACT OF EARLY DOSE ESCALATION AND TREATMENT DURATION ON HEMATOLOGIC RESPONSE
by: N. Pugliese, et al.
Published: (2025-09-01)

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups
by: Heinz Gisslinger, et al.
Published: (2020-12-01)

Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report
by: Silvio Ligia, et al.
Published: (2024-01-01)

S196: ROPEGINTERFERON ALFA-2B ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD-PV/CONTINUATION-PV STUDIES
by: H. Gisslinger, et al.
Published: (2022-06-01)

P1007: PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B IN JAPANESE PATIENTS WITH POLYCYTHEMIA VERA
by: K. Kirito, et al.
Published: (2022-06-01)

A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: findings from a phase 2 study in Chinese patients with polycythemia vera
by: Jie Jin, et al.
Published: (2023-06-01)

Hydroxyurea induced oscillations in twelve patients with polycythemia vera
by: Jan Tauscher, et al.
Published: (2010-07-01)

Mechanisms of Aging and the Preventive Effects of Resveratrol on Age-Related Diseases
by: In Soo Pyo, et al.
Published: (2020-10-01)

A therapeutic dose and its pharmacokinetics of ropeginterferon Alfa-2b for hepatitis C treatment
by: Ching-Chu Lo, et al.
Published: (2024-01-01)

Renal histopathological predictors of end-stage kidney disease in ANCA-associated vasculitis with glomerulonephritis: a single-centre study in Korea
by: Sung-Eun Choi, et al.
Published: (2023-09-01)

Chemokine expression in sera of patients with microscopic polyangiitis and granulomatosis with polyangiitis
by: Ji Eun Lee, et al.
Published: (2024-04-01)

Hereditary Fructose Intolerance Diagnosed in Adulthood
by: Min Soo Kim, et al.
Published: (2021-01-01)

Diagnostic Performance of Serum Erythropoietin to Discriminate Polycythemia Vera from Secondary Erythrocytosis through Established Subnormal Limits
by: Ji Sang Yoon, et al.
Published: (2024-08-01)

Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.
by: Soo Jin Yang, et al.
Published: (2011-01-01)

Habitat change has greater effects than climate change on butterfly occurrence in South Korea
by: Tae-Sung Kwon, et al.
Published: (2021-04-01)

Clinical implications of combined glucose intolerance in treatment-naïve hypertensive patients
by: Beom-June Kwon, et al.
Published: (2018-11-01)

N-terminal pro–B-type natriuretic peptide levels in normotensive and hypertensive dogs with myxomatous mitral valve disease stage B
by: In Sung Jang, et al.
Published: (2023-02-01)

Combined Korean Medicine Treatment of a Rare Case of Burst Fracture in an Elderly Patient with Kissing Spine
by: Eun-Young Park, et al.
Published: (2021-05-01)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
by: Pil Soo Sung, et al.
Published: (2018-09-01)

Paradoxical air embolism due to electrosurgical vaporization during hysteroscopic myomectomy
by: Young-Seok Lee, et al.
Published: (2012-03-01)

Proposal of a methodology for prediction of heavy metals concentration based on PM2.5 concentration and meteorological variables using machine learning
by: Shin-Young Park, et al.
Published: (2024-02-01)

Ropeginterferon alfa-2b shows anti-polycythaemia vera activity without causing clinically significant anaemia
by: Keita Kirito, et al.
Published: (2024-07-01)

Regulation of astrocyte activity and immune response on graphene oxide-coated titanium by electrophoretic deposition
by: Yong-Soo Han, et al.
Published: (2023-10-01)

Evaluation of moth community changes and northward shifts in response to climate warming in Korea using both local and global occurrences
by: Tae-Sung Kwon, et al.
Published: (2024-01-01)

EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
by: Pil Soo Sung, et al.
Published: (2020-05-01)

Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: A retrospective study of single institution
by: Park Jong Sup, et al.
Published: (2011-10-01)

Burst Suppression Patterns on an Electroencephalogram of an Infant with Congenital Central Hypoventilation
by: Eun Hye Lee, et al.
Published: (2016-08-01)

Optimal VPP Operation Considering Network Constraint Uncertainty of DSO
by: Sang-Yoon Park, et al.
Published: (2023-01-01)

A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19
by: Wang-Da Liu, et al.
Published: (2024-05-01)

Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea
by: Alberto Alvarez-Larrán, et al.
Published: (2017-01-01)